Please direct any media request to:
Image Building Media relations
tel: +39 02 89011300
Pharmaceutical customers will benefit from a breakthrough in pharmaceutical glass technology while patients will access safer medicines and vaccines.
One of the main obstacle to safe delivery of some biotech injectables in borosilicate containers can be glass delamination. The composition of the raw glass material, the conversion process of the glass tubing into containers and the drug formulation interaction
The construction works for the new production plant of Stevanato Group officially started today at Sete Lagoas (Minas Gerais) in Brazil, with the traditional groundbreaking ceremony, at the presence of local Authorities and company management. The Group located in Piombino Dese (Padua - Italy) is specialized in the production of glass pharamaceutical primary packaging, in the technology for the development of glass tube forming machines, visual inspection machines, assembly and packaging machines, serialization solutions.
Be updated on Ompi Events, the Web App that offers you all the info about our presence in exhibitions. You will find galleries, speech and booth's details, maps and much more. Ompi Events is the most quickly way to always be informed on our presence at events...
Ompi plans to double the production capacity of the Ompi EZ-fill Vials & Cartridges in the second quarter of 2016.
Ompi EZ-fill Vials & Cartridges solution was launched in 2010 to extend the ready to be filled container range beyond prefillable syringes.
Ompi was the pioneer in the introduction of this new concept that aims to ease the business of its customers, helping them outsourcing “non-core” activities, thereby lowering time to market, increasing quality and safety, reducing Total Cost of Ownership (TCO), and providing a common filling platform.
Nuova Ompi has been included in the European Outsourcing Awards shortlist of finalists for the "Most Improved Manufacturing Project or Process" with EZ-Fill™ CARTRIDGES.
"Organic growth", said Company President Cav. Sergio Stevanato, "is the basis of every solid industrial company. That's why, in keeping with our business plan, we have decided to begin doubling the plant in Mexico. The investment plan will initially open with the amount of 4.5 million Euros, which is expected to double early in 2012, and will reach 30 million by the time the plant has been completed."
It has been decided to provide a 4 million Euro investment a full year in advance with respect to the industrial plan, in order to initiate the second phase of the project which is dedicated to the production of sterile vials and cartridges.